Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux(Université Sorbonne Paris Nord), Ghulam J. Mufti(King's College Hospital), Eva Hellström‐Lindberg(Karolinska University Hospital), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Carlo Finelli(Istituto Oncologico Romagnolo), Aristoteles Giagounidis(St.-Johannes-Hospital Dortmund), Robert Schoch(University Hospital Schleswig-Holstein), Norbert Gattermann(Düsseldorf University Hospital), Guillermo Sanz(Hospital Universitari i Politècnic La Fe), Alan F. List(Moffitt Cancer Center), Steven D. Gore(Sidney Kimmel Comprehensive Cancer Center), John F. Seymour(Peter MacCallum Cancer Centre), John M. Bennett(University of Rochester Medical Center), John C. Byrd(The Ohio State University), Jay T. Backstrom, Linda Zimmerman, David R. McKenzie, C.L. Beach, Lewis R. Silverman(Icahn School of Medicine at Mount Sinai)
Cited by 2,636Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis